Koray Tascilar

Department of Medicine 3 – Rheumatology and Immunology

Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial (2023) Simon D, Minopoulou I, Kemenes S, Bayat S, Tascilar K, Mutlu MY, Valor-Méndez L, et al. Journal article Rationnel, état des lieux et perspectives des combinaisons de traitements de fond biologiques dans la prise en charge de la polyarthrite rhumatoïde et du rhumatisme psoriasique (2023) Mutlu MY, Tascilar K, Schett G Journal article, Review article Contrast-Enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal Tract (2023) Paulus LP, Bühler A, Wagner A, Raming R, Jüngert J, Simon D, Tascilar K, et al. Journal article 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria sets for three types of antineutrophilic cytoplasmic antibody-associated vasculitis (2023) Yazici H, Tascilar K, Yazici Y Journal article Assessment of myocardial fibrosis in patients with systemic sclerosis using [Ga-68]Ga-FAPI-04-PET-CT (2022) Treutlein C, Distler J, Tascilar K, Chenguiti Fakhouri S, Györfi AH, Atzinger A, Matei AE, et al. Journal article Neural Networks for Distinguishing Rheumatoid Arthritis from Psoriatic Arthritis by Using Magnetic Resonance Imaging (2022) Folle L, Bayat S, Kleyer A, Fagni F, Kapsner L, Schlereth M, Meinderink T, et al. Conference contribution, Abstract of a poster Efficacy and drug persistence of baricitinib monotherapy is similar to combination therapy in patients with active RA: a prospective observational study (2022) Bayat S, Tascilar K, Bohr D, Krönke G, Simon D, Knitza J, Hartmann F, et al. Journal article SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis (2022) Efe C, Tascilar K, Gerussi A, Bolis F, Lammert C, Ebik B, Stättermayer AF, et al. Journal article Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study) (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Mendez LV, Tascilar K, Krönke G, et al. Conference contribution Fibroblast Activation in Psoriasis Patients Assessed by Ga-68-FAPI-04 PET-CT Is Associated with Progression to Psoriatic Arthritis (2022) Fagni F, Simon D, Kleyer A, Tascilar K, Taubmann J, Bayat S, Minopoulou I, et al. Conference contribution